|
|||||||||||
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
Our Team
Dr. Bengt Westrin, Assoc. Professor | Partner Dr Bengt Westrin joined Ventac Partners in June 2010. He has 18 years industry experience spanning from startups to big pharma, and from product development and regulatory affairs to project management and business development. Prior to joining Ventac Partners he was CEO at the Karolinska Development company Lipopeptide AB in Stockholm (www.lipopeptide.se) and prior to that, Vice President Business Development at the drug delivery company Camurus AB (www.camurus.com). From an office at the Biomedical Center in Lund, Sweden, Dr Westrin is currently CEO of Idogen AB, which was co-founded by Ventac Partners in 2008. In addition, he is advising a number of startup companies regarding business planning and CMC matters. Dr. Westrin received his M Sc and his PhD at the Faculty of Engineering at Lund University, and is Assoc Professor at the Dept of Chemical Engineering since 1999. |
Bengt Westrin, PhD |
